|
HY-111551-50mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
|
HY-111551-1mL
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-12325-10mg
|
MedChemexpress LLC
|
GSK2194069 [CAS 1332331-08-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12325-100mg
|
MedChemexpress LLC
|
GSK2194069 [CAS 1332331-08-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12325-5mg
|
MedChemexpress LLC
|
GSK2194069 [CAS 1332331-08-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12325-50mg
|
MedChemexpress LLC
|
GSK2194069 [CAS 1332331-08-4]
|
|
Cancer-programmed cell death
|
|
|
HY-12325-1mL
|
MedChemexpress LLC
|
GSK2194069 [CAS 1332331-08-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-128144-10mg
|
MedChemexpress LLC
|
Lalistat 2 [CAS 1234569-09-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-128144-100mg
|
MedChemexpress LLC
|
Lalistat 2 [CAS 1234569-09-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-128144-5mg
|
MedChemexpress LLC
|
Lalistat 2 [CAS 1234569-09-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-128144-50mg
|
MedChemexpress LLC
|
Lalistat 2 [CAS 1234569-09-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-128144-1mL
|
MedChemexpress LLC
|
Lalistat 2 [CAS 1234569-09-5] (10mM in DMSO)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-W014004-10mg
|
MedChemexpress LLC
|
m-Carboxycinnamic acid bishydroxamide [CAS 174664-65-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W014004-5mg
|
MedChemexpress LLC
|
m-Carboxycinnamic acid bishydroxamide [CAS 174664-65-4]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-1mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-10mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-100mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-5mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-50mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-1mL
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
